Background The emergence and spread of resistance in Plasmodium falciparum malaria to
artemisinin combination therapies in the Greater Mekong subregion poses a major threat to …

Background Artemisinin and partner-drug resistance in Plasmodium falciparum are major
threats to malaria control and elimination. Triple artemisinin-based combination therapies (…

Protective immunity to the liver stage of the malaria parasite can be conferred by vaccine-induced
T cells, but no subunit vaccination approach based on cellular immunity has shown …

Background Primaquine is the only widely used drug that prevents Plasmodium vivax malaria
relapses, but adherence to the standard 14-day regimen is poor. We aimed to assess the …

Objectives To understand the impact of COVID-19 and public health measures on different
social groups, we conducted a mixed-methods study in five countries (‘SEBCOV—social, …

Background Late treatment failures after artemisinin-based combination therapies (ACTs)
for falciparum malaria have increased in the Greater Mekong subregion in southeast Asia. …

Background In southeast Asia, antibiotic prescription in febrile patients attending primary care
is common, and a probable contributor to the high burden of antimicrobial resistance. The …

Background Malaria in the eastern Greater Mekong subregion has declined to historic lows.
Countries in the Greater Mekong subregion are accelerating malaria elimination in the …

Background The appropriate antibiotic treatment for severe scrub typhus, a neglected but
widespread reemerging zoonotic infection, is unclear. Methods In this multicenter, double-blind…

Background Health-related research funders, regulators and journals expect that de-identified
individual-level health data be shared widely, with as few restrictions as possible; yet, in …